Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105001042A reveals high-yield trifluoromethylation. Enables cost reduction and supply chain reliability for fine chemical intermediates globally.
Novel patent CN108358783B details a safe, mild route for glutaric derivatives, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Novel NHC catalyzed visible light synthesis method offers green efficient production for pharmaceutical intermediates supply chain.
Patent CN104311407B reveals ionic liquid catalysis for high-purity β-IP. Offers cost reduction and supply reliability for vitamin E intermediates.
Patent CN108358783B details a safe, scalable route for 3-substituted glutaric diesters using malonic esters, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN108467388A details improved Afatinib synthesis avoiding cis-trans isomers, ensuring high purity and supply chain stability for pharmaceutical manufacturing.
Patent CN110229796B details enzymatic synthesis for high-purity duloxetine intermediates. Offers cost reduction and supply chain reliability for pharma manufacturing.
Novel catalytic hydrogenation route for 2-Amino-4-nitrophenol. Reduces pollution and enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107602652A enables high-purity reference substance production for methylprednisolone impurity control and supply chain stability.
Advanced refining method for Lenvatinib Mesylate achieving >99.8% purity. Optimized crystallization reduces costs and ensures supply chain reliability for pharmaceutical manufacturers.
Patent CN110951799A reveals a novel whole-cell enzymatic route for high-purity (2S,3R)-p-methylsulfonylphenylserine, offering significant cost reduction and scalable green manufacturing for antibiotic intermediates.
Patent CN119776462A reveals one-pot enzymatic synthesis for pseudouridine. High purity and yield offer significant supply chain and cost advantages for mRNA manufacturers.
Novel E. coli pathway boosts ergothioneine yield. Cost-effective fermentation for nutritional ingredients. Supply chain reliability ensured.
Patent CN111747827A reveals efficient oxidative coupling for biphenyl pyrogallol intermediates. Enables cost reduction in fine chemical manufacturing and scalable ligand synthesis.
Patent CN110804038B reveals a safer zinc-catalyzed route for tedizolid phosphate intermediates, offering high purity and industrial scalability for API manufacturing.
Patent CN103936809B reveals improved synthesis for dexamethasone phosphate intermediate ensuring higher purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN108997229A reveals mild synthesis for high-purity intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturing partners.
Patent CN115215809B reveals a high-yield route for oxazepam intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN106432388B details a 4-step synthesis for Sofosbuvir intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.